Ibrutinib in Combination with Lenalidomide Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma (AFT-15).
      Google Scholar   
Citation:
Cancers (Basel) vol 17 (15) 2433
Year:
2025
Type:
Manuscript
Funding:
AFT
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
14
Parents:
4126  
Children:
None
Program:
OGC
Primary Committee:
Myeloma
Sec. Committees:
   
Pharmas:
Pharmacyclics  
Grants:
 
Corr. Author:
 
Authors:
                       
Networks:
IL017, LAPS-IL036, LAPS-MA036, LAPS-NY016, LAPS-OH007, NC002, OH008, RI005   
Study
AFT-15
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
1/2
Keywords: